68 Recruiting Metastatic Melanoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Metastatic Melanoma
Related Conditions
Top Recruiting Metastatic Melanoma Studies
Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)
📍 Mid Florida Hematology and Oncology Center — Orange City, Florida
View Study & Checklist ➔Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies
📍 Mayo Clinic in Florida — Jacksonville, Florida
View Study & Checklist ➔Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
📍 James Graham Brown Cancer Center — Louisville, Kentucky
View Study & Checklist ➔Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.
📍 Providence Cancer Center — Portland, Oregon
View Study & Checklist ➔PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma
📍 Lancaster General Hospital — Lancaster, Pennsylvania
View Study & Checklist ➔A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy
📍 Hartford Healthcare Alliance (Data Collection Only) — Hartford, Connecticut
View Study & Checklist ➔A Study of LN-144 in People With Metastatic Melanoma to the Brain
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
View Study & Checklist ➔ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
📍 NYU Langone Health — New York, New York
View Study & Checklist ➔GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
📍 Providence Portland Medical Center — Portland, Oregon
View Study & Checklist ➔Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma
📍 University Health Network — Toronto, Ontario
View Study & Checklist ➔Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
📍 University of Iowa — Iowa City, Iowa
View Study & Checklist ➔IL-17 Blockade to Decrease irAEs (REPLAY)
📍 Duke University Health System — Durham, North Carolina
View Study & Checklist ➔Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
📍 University of Alabama at Birmingham: The Kirklin Clinic — Birmingham, Alabama
View Study & Checklist ➔Cryoablation+Ipilimumab+Nivolumab in Melanoma
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
📍 UW Hospital and Clinics — Madison, Wisconsin
View Study & Checklist ➔Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔